Your Article Summary
See Latest ArticlesFluocinolone Acetonide 0.01% in Peanut Oil: Safety and Efficacy Data in the Treatment of Childhood Atopic Dermatitis in Infants as Young as 3 Months of Age
Pediatric Dermatology, 06/26/09
Dohil MA et al. - Results of the study support the safety and efficacy of fluocinolone acetonide 0.01% in refined peanut oil vehicle, for infants as young as 3 months of age with atopic dermatitis. No evidence of adrenal suppression or adverse local effects was demonstrated after 4 weeks of twice daily treatment.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09
Clinical Importance of Purulence in Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections
Journal of the American Board of Family Medicine, 11/09/09
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Solar urticaria
Allergy and Asthma Proceedings, 10/12/09
The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Allergy, 11/16/09
Today in Pediatric Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Skin fusion on the fingers and toes of an adolescent girl
The Clinical Advisor, 09/10/09
Irregular purplish blue markings on the limbs of a newborn
The Clinical Advisor, 11/11/09
Severe pruritic rash, fever, and malaise
The Clinical Advisor, 11/10/09